These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10764308)

  • 1. Idiopathic pulmonary fibrosis: Impact of oxygen and colchicine, prednisone, or no therapy on survival.
    Douglas WW; Ryu JH; Schroeder DR
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1172-8. PubMed ID: 10764308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group.
    Douglas WW; Ryu JH; Swensen SJ; Offord KP; Schroeder DR; Caron GM; DeRemee RA
    Am J Respir Crit Care Med; 1998 Jul; 158(1):220-5. PubMed ID: 9655733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine, cyclophosphamide and prednisone in the treatment of mild-moderate idiopathic pulmonary fibrosis: comparison of three currently available therapeutic regimens.
    Fiorucci E; Lucantoni G; Paone G; Zotti M; Li BE; Serpilli M; Regimenti P; Cammarella I; Puglisi G; Schmid G
    Eur Rev Med Pharmacol Sci; 2008; 12(2):105-11. PubMed ID: 18575160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis.
    Bjoraker JA; Ryu JH; Edwin MK; Myers JL; Tazelaar HD; Schroeder DR; Offord KP
    Am J Respir Crit Care Med; 1998 Jan; 157(1):199-203. PubMed ID: 9445300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic pulmonary fibrosis: predicting response to therapy and survival.
    Gay SE; Kazerooni EA; Toews GB; Lynch JP; Gross BH; Cascade PN; Spizarny DL; Flint A; Schork MA; Whyte RI; Popovich J; Hyzy R; Martinez FJ
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1063-72. PubMed ID: 9563720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial.
    Raghu G; Depaso WJ; Cain K; Hammar SP; Wetzel CE; Dreis DF; Hutchinson J; Pardee NE; Winterbauer RH
    Am Rev Respir Dis; 1991 Aug; 144(2):291-6. PubMed ID: 1859050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine, D-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: a controlled clinical trial.
    Selman M; Carrillo G; Salas J; Padilla RP; Pérez-Chavira R; Sansores R; Chapela R
    Chest; 1998 Aug; 114(2):507-12. PubMed ID: 9726738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colchicine versus prednisone as treatment of usual interstitial pneumonia.
    Douglas WW; Ryu JH; Bjoraker JA; Schroeder DR; Myers JL; Tazelaar HD; Swensen SJ; Scanlon PD; Peters SG; DeRemee RA
    Mayo Clin Proc; 1997 Mar; 72(3):201-9. PubMed ID: 9070193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis.
    Antoniou KM; Nicholson AG; Dimadi M; Malagari K; Latsi P; Rapti A; Tzanakis N; Trigidou R; Polychronopoulos V; Bouros D
    Eur Respir J; 2006 Sep; 28(3):496-504. PubMed ID: 16611657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose acetylcysteine in idiopathic pulmonary fibrosis.
    Demedts M; Behr J; Buhl R; Costabel U; Dekhuijzen R; Jansen HM; MacNee W; Thomeer M; Wallaert B; Laurent F; Nicholson AG; Verbeken EK; Verschakelen J; Flower CD; Capron F; Petruzzelli S; De Vuyst P; van den Bosch JM; Rodriguez-Becerra E; Corvasce G; Lankhorst I; Sardina M; Montanari M;
    N Engl J Med; 2005 Nov; 353(21):2229-42. PubMed ID: 16306520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does colchicine decrease the rate of recurrence of acute idiopathic pericarditis treated with glucocorticoids?
    Mager A; Talmor Y; Chezar Azzerad C; Iakobishvili Z; Porter A; Kornowski R; Hasdai D
    J Cardiol; 2018 Apr; 71(4):409-413. PubMed ID: 29198919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Idiopathic pulmonary fibrosis; description of a Dutch cohort].
    Barlo NP; van Moorsel CH; van den Bosch JM; van de Graaf EA; Kwakkel-van Erp JM; Grutters JC
    Ned Tijdschr Geneeskd; 2009; 153():B425. PubMed ID: 19785823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality.
    King TE; Schwarz MI; Brown K; Tooze JA; Colby TV; Waldron JA; Flint A; Thurlbeck W; Cherniack RM
    Am J Respir Crit Care Med; 2001 Sep; 164(6):1025-32. PubMed ID: 11587991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis.
    Nicholson AG; Fulford LG; Colby TV; du Bois RM; Hansell DM; Wells AU
    Am J Respir Crit Care Med; 2002 Jul; 166(2):173-7. PubMed ID: 12119229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of response to immunosuppressive therapy in idiopathic pulmonary fibrosis.
    van Oortegem K; Wallaert B; Marquette CH; Ramon P; Perez T; Lafitte JJ; Tonnel AB
    Eur Respir J; 1994 Nov; 7(11):1950-7. PubMed ID: 7875264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and functional outcomes in Middle Eastern patients with idiopathic pulmonary fibrosis.
    Alhamad EH; Masood M; Shaik SA; Arafah M
    Clin Respir J; 2008 Oct; 2(4):220-6. PubMed ID: 20298338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine in the treatment of pulmonary fibrosis.
    Peters SG; McDougall JC; Douglas WW; Coles DT; DeRemee RA
    Chest; 1993 Jan; 103(1):101-4. PubMed ID: 8417861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of idiopathic pulmonary fibrosis].
    Nicod LP
    Schweiz Med Wochenschr; 1995 Mar; 125(10):483-8. PubMed ID: 7892561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of fibroblastic foci in usual interstitial pneumonia and non-specific interstitial pneumonia.
    Harada T; Watanabe K; Nabeshima K; Hamasaki M; Iwasaki H
    Respirology; 2013 Feb; 18(2):278-83. PubMed ID: 23016880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis.
    Collard HR; King TE; Bartelson BB; Vourlekis JS; Schwarz MI; Brown KK
    Am J Respir Crit Care Med; 2003 Sep; 168(5):538-42. PubMed ID: 12773325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.